{"DataElement":{"publicId":"2185969","version":"1","preferredName":"Hematology Hemoglobin Assessment Yes No Indicator","preferredDefinition":"the yes/no indicator whether there was a hematology assessment for hemoglobin, the red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.","longName":"HMT_HGB_ASSESS_IND2","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3533989","version":"1","preferredName":"Hematology Hemoglobin Assessment","preferredDefinition":"information related to hematology assessment for hemoglobin, the red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.","longName":"HMT_HB_ASSESSMENT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177090","version":"1","preferredName":"Hematology","preferredDefinition":"Hematology; the branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.","longName":"Hematology","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Hematology","conceptCode":"C16673","definition":"The branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A70-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3533987","version":"1","preferredName":"Hemoglobin Physical Examination","preferredDefinition":"The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.:A physical examination is a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual's health assessment.","longName":"C16676:C20989","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin","conceptCode":"C16676","definition":"The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C533BE39-7B9C-8D94-E040-BB89AD435D74","latestVersionIndicator":"Yes","beginDate":"2012-07-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-19","modifiedBy":"ONEDATA","dateModified":"2012-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C533BE39-7BAD-8D94-E040-BB89AD435D74","latestVersionIndicator":"Yes","beginDate":"2012-07-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104903","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"10000427","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"10000426","version":"1","longName":"GOG-0170R","context":"NRG"},{"publicId":"4104881","version":"1","longName":"GOG-0227G","context":"NRG"},{"publicId":"4104890","version":"1","longName":"GOG-0229L","context":"NRG"},{"publicId":"4104891","version":"1","longName":"GOG-0229N","context":"NRG"},{"publicId":"4104941","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000705","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"4104900","version":"1","longName":"GOG-0277","context":"NRG"},{"publicId":"4104892","version":"1","longName":"GOG-0229O","context":"NRG"}]},{"publicId":"4254096","version":"1","longName":"Protocol Phase","context":"PBTC","ClassificationSchemeItems":[{"publicId":"10000103","version":"1","longName":"Phase I","context":"PBTC"},{"publicId":"4254119","version":"1","longName":"PBTC-042","context":"PBTC"}]}],"AlternateNames":[{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"HMT_HGB_ASSESS_IND2","type":"USED_BY","context":"NRG"},{"name":"HMT_HGB_ASSESS_IND2","type":"USED_BY","context":"CITN"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"Hgb >=9 g/dL","type":"Preferred Question Text","description":"Hgb >=9 g/dL","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Hemoglobin >9.0 g/dL","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Hemoglobin >=9 g/dL","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"HgB >=10.0 g/dL","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Hemoglobin >= 9.5 g/dL","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Hemoglobin greater than or equal to 9 g/dL?","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Hemoglobin >=9.0 g/dL","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Hemoglobin >=8 g/dL","url":null,"context":"CTEP"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Hemoglobin >8 g/dL","url":null,"context":"CTEP"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Is the Hemoglobin greater than 8.0 mg/dl (equals 80 g/L; or 4.9 mmol/L)?","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Hemoglobin (Hgb)>=10 g/dL","url":null,"context":"CTEP"},{"name":"AECC Text 1","type":"Alternate Question Text","description":"Is subject's Hemoglobin >= 9 g/dl (per manufacturer recommendation)?","url":null,"context":"AECC"},{"name":"CRF Text 11","type":"Alternate Question Text","description":"Hemoglobin (Hgb) >=9g/dL","url":null,"context":"CTEP"},{"name":"NRG_CRF Text","type":"Alternate Question Text","description":"Hemoglobin (Must be greater than or equal to 10g/dl)","url":null,"context":"NRG"},{"name":"CRF Text 14","type":"Alternate Question Text","description":"Hemoglobin (Hgb) >9 g/dL","url":null,"context":"CTEP"},{"name":"CRF Text 13","type":"Alternate Question Text","description":"Hemoglobin >= 8.0 g/dl within 30 days prior to registration on study?","url":null,"context":"CTEP"},{"name":"CRF Text 15","type":"Alternate Question Text","description":"Hemoglobin >11 g/dL","url":null,"context":"CTEP"},{"name":"CRF Text 12","type":"Alternate Question Text","description":"Hemoglobin >=9g/dL (may be transfused but must be stable without clinical evidence of ongoing blood loss or hemolysis)","url":null,"context":"CTEP"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Hemoglobin >= 8 g/dL","url":null,"context":"PBTC"},{"name":"CRF Text18","type":"Alternate Question Text","description":"Hemoglobin >=9g/dl within 14 days prior to registration on study?","url":null,"context":"NRG"},{"name":"CRF Text 16","type":"Alternate Question Text","description":"Hemoglobin (Hgb) >= 10 g/dL","url":null,"context":"NRG"},{"name":"CRF Text17","type":"Alternate Question Text","description":"Hemoglobin (Hgb) is greater than or equal to 10 g/dL within 14 days prior to step 2 registration","url":null,"context":"NRG"},{"name":"CRF Text 9","type":"Alternate Question Text","description":"Hemoglobin >= 8.0 g/dl within 14 days prior to registration on study?","url":null,"context":"NRG"},{"name":"Is pre-study hemoglobin greater than or equal to 9 g/dl?","type":"Alternate Question Text","description":"Is pre-study hemoglobin greater than or equal to 9 g/dl?","url":null,"context":"Theradex"},{"name":"CRF Text 10","type":"Alternate Question Text","description":"Hemoglobin >= 9 g/dL or >= 5.6 mmol/L","url":null,"context":"CTEP"},{"name":"PBTC_Text2","type":"Alternate Question Text","description":"Hemoglobin >= 8 g/dL (may receive transfusions)","url":null,"context":"PBTC"},{"name":"CRF Text 20","type":"Alternate Question Text","description":"Hemoglobin >=9g/dL or >=5.6 mmol/L","url":null,"context":"CTEP"},{"name":"CRF Text 21","type":"Alternate Question Text","description":"Hemoglobin (Hgb) is greater than or equal to 10 g/dL within 28 days prior to step 2 registration","url":null,"context":"NRG"},{"name":"CITN","type":"Alternate Question Text","description":"Hemoglobin >9 g/dL","url":null,"context":"CITN"},{"name":"ALT - 1","type":"Alternate Question Text","description":"Does participant have Hemoglobin greater than or equal to 10.0 g/dL?","url":null,"context":"ECOG-ACRIN"},{"name":"CITN Text","type":"Alternate Question Text","description":"Hemoglobin >=10g/dL (may be transfused but must be stable without clinical evidence of ongoing blood loss or hemolysis)","url":null,"context":"CITN"},{"name":"CRF Text 22","type":"Alternate Question Text","description":"Is hemoglobin >= 8g/dL","url":null,"context":"CTEP"},{"name":"CRF Text 23","type":"Alternate Question Text","description":"Is hemoglobin >= 8.0g/dL?","url":null,"context":"CTEP"},{"name":"CRF Text 24","type":"Alternate Question Text","description":"Is hemoglobin > 10g/dL with no blood transfusion in the past 28 days?","url":null,"context":"CTEP"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 8 g/dL? (can be transfused with red blood cells pre-study)","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Is hemoglobin >= 8 g/dL (can be transfused with red blood cells pre-study)","url":null,"context":"NRG"},{"name":"CRF Text 25","type":"Alternate Question Text","description":"Does the patient have Hemoglobin value greater than or equal to 8 g/dL?","url":null,"context":"CTEP"},{"name":"CRF TEXT 26","type":"Alternate Question Text","description":"Is Hemoglobin >= 10 g/dL within 14 days prior to registration","url":null,"context":"NRG"},{"name":"NRG-eCRF_Text","type":"Alternate Question Text","description":"Is hemoglobin equal or greater than 10g/dL with no blood transfusion in the past 28 days?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_2","type":"Alternate Question Text","description":"Hemoglobin greater than or equal to 10g/dL?","url":null,"context":"NRG"},{"name":"CRF Text 27","type":"Alternate Question Text","description":"Is hemoglobin greater than 10g/dL?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_3","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 10g/dL with no blood transfusion in the past 28 days?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_5","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 9 g/dL within 28 days before randomization?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_6","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 8g/dL?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_4","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 9 g/dL within 28 days before study entry?","url":null,"context":"NRG"},{"name":"NEG_eCRF_Text_7","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 10 g/dL within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_7","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 9g/dL within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_CRF Text_1","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 9.5g/dL within 14 days prior to registration and no blood transfusion in the past 28 days?","url":null,"context":"NRG"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Is hemoglobin level greater than or equal to 10 g/dL within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG CRF Text 2","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 10g/dL within 14 days prior to second registration?","url":null,"context":"NRG"},{"name":"NRG CRF Text 3","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 8g/dL?","url":null,"context":"NRG"},{"name":"NRG CRF Text 4","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 9g/dL (in the absence of transfusion within 28 days prior to dosing)?","url":null,"context":"NRG"},{"name":"NRG CRF Text 5","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 10 g/dL within 16 weeks prior to pre-entry?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_8","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 9 g/dL within 28 days before Step 1/Study entry?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_9","type":"Alternate Question Text","description":"Is hemoglobin level greater than or equal to 10 g/dL?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_10","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 10g/dL?","url":null,"context":"NRG"},{"name":"NRG CRF Text 6","type":"Alternate Question Text","description":"Is hemoglobin greater than or equal to 9g/dL?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFE1F96E-A84F-148E-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-07-23","modifiedBy":"TYRRELLM","dateModified":"2023-10-23","changeDescription":"Replaced VD Assessments Ind-2 2018320v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"10.23.23 Added AQT per request ticket CADSR0002989_mmt\r\n9.29.2023 Added AQT per request CADSR0002902 _mmt\r\n9.29.2023 Added AQT per request CADSR0002901_mmt\r\n9.28.2023 Added AQT per request CADSR0002895_mmt\r\n2022.12.20 AQT added for ticket request CADSR0001812. ak 2022.11.15 AQT added for ticket request CADSR0001687. ak","unresolvedIssues":null,"deletedIndicator":"No"}}